Code | 69868 | ||||||||||
MA number | EU/1/09/508/005 | ||||||||||
Product Form: | sus inj 1x0,5 ml (1 napl.inj.striek.+ 2 ihly) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | GlaxoSmithKline Biologicals S.A., Belgium | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 30.03.2009 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 14.12.2018 |